<DOC>
	<DOCNO>NCT00926835</DOCNO>
	<brief_summary>The primary purpose study investigate effectiveness antidepressant treatment non-psychotic major depressive disorder ( MDD ) Korea . The study divide MDD patient 3 level group accord past history treatment compare effectiveness various treatment regimen level . The treatment level group : 1 ) patient never treat appropriate medication current depressive symptom , 2 ) receive appropriate SSRI ( Selective Serotonin Reuptake Inhibitor ) respond , 3 ) receive two type SSRI antidepressant treatment without much effect reduce depressive symptom . The first level group treat single SSRI antidepressant treatment . The second third level group , receive SSRI treatment , treat alternative SSRI antidepressant ( switch ) , combine multiple SSRI treatment ( antidepressant combination ) , SSRI treatment combine mood stabilizer anti-psychotics ( augmentation ) . This study use placebo . Patients visit 5 time 6 week level treatment . Patients evaluated severity depressive symptom , functional level , side effect visit . Afterwards , investigation combine monitor patient depressive symptom every 3 month next 24 month . 18 nationwide university hospital participate study . This multi-site , prospective , naturalistic study patient depression Korea main project 'Clinical Research Center Depression ' fund Ministry Health , Welfare , Family Affairs ( MIHWAF ) Korea highly-qualified research achievement .</brief_summary>
	<brief_title>Effect Antidepressants Treatment Korean Major Depressive Disorder Patients</brief_title>
	<detailed_description>Patients classify 3 level past therapeutic history : Level 1 : Patients receive appropriate treatment current major depressive episode . Level 2 : Patients never show satisfactory response adequate dosage Paroxetine sufficient period current major depressive episode . Level 3 : Patients without satisfactory response two antidepressant include one Paroxetine Escitalopram sufficient period . A satisfactory response mean baseline HAM-D17 score reduce 50 % HAM-D17 score 10 sufficient period mean 6 week . Patients randomly assign follow treatment group . Patients level 1 randomly assign treatment group among Paroxetine monotherapy , Escitalopram monotherapy , Venlafaxine monotherapy . Patients level 2 enrol medicate Paroxetine monotherapy level 1 assign one follow 4 group ; Escitalopram monotherapy , Venlafaxine monotherapy , Paroxetine combine Venlafaxine , Paroxetine augment Lithium . Patients level 3 randomly assign one follow 4 group : 1 ) Either Paroxetine combine Lamotrigine Paroxetine combine Bupropion resist two antidepressant include Paroxetine . 2 ) Either Escitalopram combine Mirtazapine Escitalopram combine Aripiprazole resist two antidepressant include Escitalopram . 3 ) Patients respond Paroxetine Escitalopram randomly assign either 1 ) 2 ) .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<mesh_term>Mianserin</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Clinical diagnosis nonpsychotic Major depressive disorder HAMD17 score 14 great Age 18 great 65 less patient current past history diagnosis bipolar disorder , schizophrenia , schizoaffective disorder , psychotic disorder NOS patient current psychotic feature , eat disorder obsessivecompulsive disorder patient neurological disorder patient medical condition could interfere everyday life activity pregnant lactate woman , patient current DSMIV TR Axis I diagnosis MDD need inpatient care patient treat ECT current depressive episode insufficient information past treatment current depressive episode patient pose serious suicidal risk .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>